Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD

OBJECTIVE: Iron deficiency is a common complication in patients with IBD and oral iron therapy is suggested to exacerbate IBD symptoms. We performed an open-labelled clinical trial to compare the effects of per oral (PO) versus intravenous (IV) iron replacement therapy (IRT). DESIGN: The study popul...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Thomas, Clavel, Thomas, Smirnov, Kirill, Schmidt, Annemarie, Lagkouvardos, Ilias, Walker, Alesia, Lucio, Marianna, Michalke, Bernhard, Schmitt-Kopplin, Philippe, Fedorak, Richard, Haller, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531225/
https://www.ncbi.nlm.nih.gov/pubmed/26848182
http://dx.doi.org/10.1136/gutjnl-2015-309940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531225/
https://www.ncbi.nlm.nih.gov/pubmed/26848182
http://dx.doi.org/10.1136/gutjnl-2015-309940

Ejemplares similares